Anti-calcitonin gene-related peptide monoclonal antibodies are the first approved pharmacologic treatments developed explicitly for the prevention of migraine.
Lauren J. Barton, MHS, PA-C
Lauren J. Barton, MHS, PA-C, practices in Hospital Medicine at Einstein Healthcare Network in North Philadelphia, PA.
